The timing breakthrough in liver cancer treatment
In a significant step forward for liver cancer treatment, researchers have found that a gap of at least 50 days between stopping immunotherapy and undergoing a liver transplant dramatically lowers the risk of graft rejection. This discovery offers new hope to patients battling hepatocellular carcinoma (HCC), the most common form of liver cancer globally.
Tardigrade proteins show promise in cancer care
Patients undergoing radiation therapy experience debilitating side effects because of toxicity arising from radiation-induced DNA strand breaks in normal peritumoral cells.
